Vision loss from eye diseases will increase as Americans age

April 12, 2004

With the aging of the population, the number of Americans with major eye diseases is increasing, and vision loss is becoming a major public health problem. By the year 2020, the number of people who are blind or have low vision is projected to increase substantially. These findings appear in the April issue of Archives of Ophthalmology.

Blindness or low vision affects 3.3 million Americans age 40 and over, or one in 28, according to study authors. This figure is projected to reach 5.5 million by the year 2020. The study reports that low vision and blindness increase significantly with age, particularly in people over age 65. People 80 years of age and older currently make up eight percent of the population, but account for 69 percent of blindness. The study provides the most robust and up-to-date estimates available of the burden of visual impairment. It was sponsored by the National Eye Institute (NEI), part of the Federal government's National Institutes of Health (NIH). "Blindness and low vision can lead to loss of independence and reduced quality of life," said Elias A. Zerhouni, M.D., Director of the NIH. "As our population lives longer, eye disease will be an ever greater concern. These data underscore NIH's commitment to the support of vision research that will prevent, delay, and possibly cure eye diseases."

The study identifies age-related macular degeneration (AMD), glaucoma, cataract, and diabetic retinopathy as the most common eye diseases in Americans age 40 and over. The leading cause of blindness among white Americans is AMD, accounting for 54 percent of all blindness. Among African Americans, the leading causes of blindness are cataract and glaucoma. Among Hispanics, glaucoma is the most common cause of blindness. The study authors emphasize the importance of annual comprehensive eye examinations in preventing and/or delaying eye disease for those at higher risk for blindness, such as those over age 65, people with diabetes, or African Americans over age 40.

Study authors provide estimates of the number of Americans with each disease. The authors say that due largely to the aging of the population, the prevalence of low vision and blindness will increase markedly by 2020.

There were other significant findings from the study:"These data will help identify areas where we should direct our research efforts," said NEI Director Paul A. Sieving, M.D., Ph.D. "Also, health professionals and state and local agencies can use study data to prioritize public health programs emphasizing the importance of early detection and timely treatment. Developing blindness prevention strategies could help address the potentially devastating impact of the increased prevalence of eye diseases in the next few decades."

Frederick Ferris III, M.D., director of clinical research at the NEI, said that the estimates of low vision and blindness "are the first to take full advantage of information derived from several excellent eye disease studies reported since 1990. These data, collected from different populations, allow us to identify the most common eye diseases and give us good estimates of their relative magnitudes."

The study was conducted by the Eye Disease Prevalence Research Group, a consortium of principal investigators who have conducted population-based eye disease studies. The Eye Disease Prevalence Research Group produced prevalence estimates of blindness and low vision in people age 40 and over by analyzing standardized data from several high quality studies. The derived prevalence rates were then modeled to the U.S. population using 2000 census data, and projected to 2020 based on 2020 US census estimates.
-end-
A list of the eye disease studies of various populations analyzed by the Eye Disease Prevalence Research Group, and their respective authors, is attached.

The National Eye Institute (NEI) conducts and supports research that leads to sight-saving treatments and plays a key role in reducing visual impairment and blindness. The NEI is part of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services.

Summary of Eye Disease Prevalence Data Prevalence of Cataract, Age-Related Macular Degeneration, and Open-Angle Glaucoma Among Adults 40 Years and Older in the United States*

Prevalence of Diabetic Retinopathy Among Adults* Prevalence of Blindness and Low Vision Among Adults 40 Years and Older in the United States* *Archives of Ophthalmology, Volume 122, April 2004

Eye Disease Prevalence Study Group

The Baltimore Eye Survey, Baltimore, MD: James M. Tielsch, Alfred Sommer, Joanne Katz, Harry A. Quigley

The Barbados Eye Studies, Barbados, West Indies: M. Cristina Leske, Suh-Yuh Wu, Barbara Nemesure, Anselm Hennis, Leslie Hyman, Andrew Schachat

The Beaver Dam Eye Study, Beaver Dam, WI: Barbara E.K. Klein, Ronald Klein, Kristine E. Lee, Scot E. Moss, Sandra C. Tomany

The Blue Mountains Eye Study, Sydney, New South Wales, Australia: Paul Mitchell, Jie Jin Wang, Elena Rochtchina, Wayne Smith, Robert G. Cumming, Karin Attebo, Jai Panchapakesan, Suriya Foran

The Melbourne Visual Impairment Project, Melbourne, Australia: Hugh R. Taylor, Cathy McCarty, Bickol Mukesh, LeAnn M. Weih, Patricia M. Livingston, Mylan Van Newkirk, Cara L. Fu, Peter Dimitrov, Matthew Wensor

Proyecto Vision Evaluation Research, AZ: Sheila K. West, Beatriz Muñoz, Jorge Rodriguez (deceased), Aimee T. Broman, Daniel Finklestein, Robert Snyder

The Rotterdam Eye Study, Rotterdam, the Netherlands: Paulus T.V.M. de Jong, Johannes R. Vingerling, Roger C.W. Wolfs, Caroline C.W. Klaver, Albert Hofman, Redmer van Leeuwen, M. Kamran Ikram, Simone de Voogd

The Salisbury Eye Evaluation Project, Salisbury, MD: Sheila West, Gary Rubin, Karen Bandeen Roche, Beatriz Muñoz, Kathy Turano, Oliver D. Schein, Donald Duncan

Resource Centers

Meta-Analysis Coordinating Center, Baltimore, MD: Nathan G. Congdon, David S. Friedman, John H. Kempen, Benita J. O'Colmain

National Eye Institute, National Institutes of Health, Bethesda, MD: Frederick L. Ferris III

NIH/National Eye Institute

Related Glaucoma Articles from Brightsurf:

Monitoring glaucoma at home
Glaucoma is a chronic condition that affects cells at the back of the eye.

Study finds novel mechanism that may confer protection against glaucoma
A team of researchers from LSU Health New Orleans Neuroscience Center of Excellence and the University of Copenhagen provides the first evidence that patients with ocular hypertension may exhibit superior antioxidant protection that promotes resistance to the elevated intraocular pressure associated with glaucoma.

AI-supported test for very early signs of glaucoma progression
A new test can detect glaucoma progression 18 months earlier than the current gold standard method, according to results from a UCL-sponsored clinical trial.

New method gives glaucoma researchers control over eye pressure
Neuroscientists have developed a new method that permits continuous regulation of eye pressure without damage, becoming the first to definitively prove pressure in the eye is sufficient to cause and explain glaucoma.

Glaucoma care in prison inmates
Data fromĀ 82 prison inmates treated in a glaucoma clinic at an academic hospital were used in this observational study to report on how treatment and follow-up, including medication adherence, were are managed.

New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.

Air pollution linked to higher glaucoma risk
Living in a more polluted area is associated with a greater likelihood of having glaucoma, a debilitating eye condition that can cause blindness, finds a new UCL-led study in the UK.

Long-term statin use associated with lower glaucoma risk
A new study brings the connection between statin use and risk of glaucoma into sharper focus.

Health burden of glaucoma has risen worldwide
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study.

UAlberta scientists first to pinpoint a cause of pigmentary glaucoma
An international team of researchers has identified a gene responsible for the onset of pigmentary glaucoma, which may lead to new therapies for the condition.

Read More: Glaucoma News and Glaucoma Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.